PanKind, The Australian Pancreatic Cancer Foundation, is investing in cutting-edge medical research at institutions across Australia with the aim of tripling the pancreatic cancer survival rate by 2030.

The Foundation aims to achieve this through a strategic focus on raising awareness, collaborations to increase progress and investing in ground-breaking medical research – and the 2023 PanKind Research Grant round will open on 5 June, with funding to support Australian researchers helping people with pancreatic cancer.

The available grants in 2023 include Early Detection Innovation grants and New Treatment Accelerator grants, with applications assessed by PanKind’s internationally renowned Scientific Advisory Panel of scientists and clinicians.

Application Timeline:

• Monday, 5 June: Applications open for Innovation and Accelerator categories.
• Monday, 31 July: Applications close. Submissions will not be accepted after 5pm AEST.
• November 2023: Grant recipients announced.

Find out more about the available grants, application process and eligibility criteria on the PanKind website.

For more detailed information, please contact Kristjan Porm, head of Marketing and Communications for the Foundation, by email at kristjan@pankind.org.au or phone 0402 158 726.